Which air pollutants are most strongly linked to Parkinson's disease?
The strongest and most consistent evidence points to two pollutants: fine particulate matter (PM2.5) and nitrogen dioxide (NO2). PM2.5 are tiny particles small enough to enter the bloodstream and reach the brain, while NO2 is a gas from traffic and industry. A 2024 study of 346 Parkinson's patients and over 4,800 controls found that people in the highest PM2.5 exposure group had a 23% higher risk of Parkinson's compared to the lowest group [2]. The same study showed that higher NO2 exposure raised risk by 13% [2]. Another large 2021 study of nearly 79,000 people in Korea reported that those with the highest NO2 exposure had a 41% higher risk of developing Parkinson's [1]. A 2024 analysis of over 47,000 US women found that for every small increase in NO2, Parkinson's risk rose by 22% [3]. These findings are backed by a 2022 meta-analysis that pooled data from multiple studies and confirmed a small but significant risk increase for NO2 and PM2.5 [6].
Traffic-related pollution appears especially harmful. A 2023 study in central California looked at carbon monoxide (a marker of traffic pollution) and PM2.5 at both homes and workplaces. It found that people with the highest traffic-related pollution at home had a 58% higher risk of Parkinson's, and those with the highest workplace exposure had a 91% higher risk [5]. A 2021 study in China also linked PM2.5 and PM10 to increased Parkinson's risk, with PM2.5 raising risk by 51% per increase in pollution levels [4]. Together, these studies strongly suggest that living or working in areas with high traffic-related air pollution raises Parkinson's risk.
How could breathing polluted air lead to Parkinson's?
Scientists believe air pollution particles can travel from the lungs into the bloodstream and then cross into the brain, where they trigger inflammation and oxidative stress—two processes known to damage dopamine-producing neurons that are lost in Parkinson's. A 2026 study using blood samples from 616 Parkinson's patients and 271 controls found that people exposed to higher PM2.5 and traffic-related pollutants had disrupted metabolic pathways linked to inflammation, lipid metabolism, and dopamine production [10]. Specifically, they found reduced levels of tyrosine (a building block for dopamine) and increased markers of inflammation like leukotrienes [10]. This provides direct biological evidence for how air pollution might contribute to Parkinson's at a molecular level.
Animal and cell studies have shown that fine particles can cause inflammation in the brain's immune cells (microglia) and damage mitochondria—the energy factories of cells. A 2024 Mendelian randomization study, which uses genetic data to infer cause-and-effect, found that genetically predicted NO2 exposure was associated with a fourfold higher risk of Parkinson's, supporting a causal link [8]. Another 2024 study using advanced statistical methods in the UK Biobank (nearly 294,000 people) concluded that PM2.5 likely causes Parkinson's, with a 23% higher risk per unit increase in PM2.5 [7]. These findings strengthen the case that air pollution doesn't just correlate with Parkinson's—it may directly contribute to the disease.
Why don't all studies find the same link?
Not every study agrees, and the differences often come down to how pollution is measured, the population studied, and the length of follow-up. A 2025 study from Northern Ireland, which tracked over 28% of the population, found no overall link between PM2.5 or NO2 and Parkinson's in the general population [9]. However, it did find a positive association in people under 50, suggesting that younger people might be more vulnerable [9]. This study used a different method to identify Parkinson's cases (first receipt of medication) and a shorter follow-up period, which might explain the discrepancy.
Some studies also find stronger effects for certain pollutants than others. For example, the 2021 Korean study found a significant link only for NO2, not for PM2.5 or other pollutants [1]. In contrast, the 2024 US Sister Study found a strong link for NO2 but not for PM2.5 overall, except in women from the Midwest [3]. A 2022 meta-analysis noted high variability across studies, meaning results were not always consistent [6]. These differences highlight that the relationship is complex and may depend on local pollution mixtures, individual susceptibility, and how exposure is measured. Overall, though, the majority of large, well-designed studies point to a real increase in risk.
About These Sources
This answer is built on 10 peer-reviewed studies — published from 2021 to 2026, 5 from 2024 or later, 8 in Q1 journals, collectively cited 316 times — selected as the most relevant from 12 studies that passed quality screening, drawn from 33 papers retrieved from a database of over 500 million.
Sources used in this answer
Association of NO <sub>2</sub> and Other Air Pollution Exposures With the Risk of Parkinson Disease
In a large Korean cohort of 78,830 adults, those with the highest NO2 exposure had a 41% higher risk of Parkinson's compared to the lowest; no significant link was found for PM2.5, PM10, ozone, sulfur dioxide, or carbon monoxide.
Air Pollution and Parkinson Disease in a Population-Based Study
In a US case-control study of 346 Parkinson's patients and 4,813 controls, higher PM2.5 exposure was linked to a 23% higher risk of Parkinson's, and higher NO2 to a 13% higher risk; PM2.5 also increased the risk of a more severe form (akinetic rigid) by 36% and dyskinesia by 42%.
Air Pollutants and Risk of Parkinson’s Disease among Women in the Sister Study
In a prospective study of 47,108 US women, each increase in NO2 was associated with a 22% higher risk of Parkinson's; PM2.5 was not linked overall, except in women from the Midwest where risk rose 149%.
Air pollution, surrounding green, road proximity and Parkinson's disease: A prospective cohort study
In a Chinese cohort of 47,516 people, PM2.5 was associated with a 51% higher risk of Parkinson's per increase in pollution; surrounding green space was linked to a 20% lower risk.
Traffic-related air pollution and Parkinson's disease in central California
In a California case-control study of 761 Parkinson's patients and 910 controls, traffic-related carbon monoxide at residences raised Parkinson's risk by 58%, and at workplaces by 91%; PM2.5 raised risk by 62% at residences and 85% at workplaces.
Is ambient air pollution a risk factor for Parkinson's disease? A meta-analysis of epidemiological evidence
In a meta-analysis of epidemiological studies, NO2 and ozone were each associated with a 1% increase in Parkinson's risk per unit increase; PM2.5 and carbon monoxide showed non-significant trends.
Causal association between long-term exposure to air pollution and incident Parkinson’s disease
In a UK Biobank study of 293,888 people, each 1 μg/m³ increase in PM2.5 was associated with a 23% higher risk of Parkinson's, and causal analysis supported a direct effect.
Exploring the association between air pollution and Parkinson’s disease or Alzheimer’s disease: a Mendelian randomization study
In a Mendelian randomization study using genetic data, genetically predicted NO2 exposure was associated with a fourfold higher risk of Parkinson's; PM10 was linked to Alzheimer's.
Exposure to ambient air pollution and onset of Parkinson’s disease in a large cohort study
In a Northern Ireland cohort of 28% of the population, no overall link was found between PM2.5 or NO2 and Parkinson's, but a positive association was seen in people under 50.
Untargeted serum metabolomics and air pollution in Parkinson's disease.
In a metabolomics study of 616 Parkinson's patients and 271 controls, air pollution exposure was linked to disrupted pathways in inflammation, lipid metabolism, and dopamine synthesis, including reduced tyrosine and increased leukotrienes.
